investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Peter Kent Jackson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Peter Kent Jackson

Stanford University

Stanford, United States

Related projects

Michele Carbone

Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection

Trachea, bronchus and lung

Pathology

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Trachea, bronchus and lung

Roman Perez-Soler

Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy

Trachea, bronchus and lung

Katarzyna Slowinska

Rigid-rod Peptides as Nanocarriers for Delivery of Cancer Drugs

Trachea, bronchus and lung

Sherry L Emery

Tobacco Control in a Rapidly Changing Media Environment

Trachea, bronchus and lung

Charles M. Rudin

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Trachea, bronchus and lung

Pinar Ozden Eser

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Trachea, bronchus and lung

Bruce E. Johnson

EGFR Mutations in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Christopher S Garris

The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy

Trachea, bronchus and lung